Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors

V De Luca, A Angeli, A Nocentini, P Gratteri… - International Journal of …, 2024 - mdpi.com
The implementation of innovative approaches is crucial in an ongoing endeavor to mitigate
the impact of COVID-19 pandemic. The present study examines the strategic application of …

[HTML][HTML] The effect of oral antiviral therapy for COVID-19 in managing non-hospitalized patients with lung cancer

WH Hsu, BW Shiau, YW Tsai, JY Wu, PY Huang… - Journal of Infection and …, 2024 - Elsevier
Backgrounds The effectiveness of oral antiviral therapy including nirmatrelvir plus ritonavir
and molnupiravir in managing COVID-19 among individuals with pre-existing lung cancer …

Clinical effectiveness of nirmatrelvir plus ritonavir on the short‐and long‐term outcome in high‐risk children with COVID‐19

JY Wu, CC Chen, MY Liu, WH Hsu… - Journal of Medical …, 2024 - Wiley Online Library
This study investigated the clinical effectiveness of nirmatrelvir plus ritonavir (NMV‐r) on
short‐term outcome and the risk of postacute sequelae of severe acute respiratory syndrome …